KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Jazz Pharmaceuticals (JAZZ) Tax Provisions (2016 - 2025)

Historic Tax Provisions for Jazz Pharmaceuticals (JAZZ) over the last 14 years, with Q3 2025 value amounting to -$242.4 million.

  • Jazz Pharmaceuticals' Tax Provisions fell 156809.33% to -$242.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$332.1 million, marking a year-over-year decrease of 39843.75%. This contributed to the annual value of -$91.4 million for FY2024, which is 2375.33% up from last year.
  • Latest data reveals that Jazz Pharmaceuticals reported Tax Provisions of -$242.4 million as of Q3 2025, which was down 156809.33% from -$17.2 million recorded in Q2 2025.
  • Over the past 5 years, Jazz Pharmaceuticals' Tax Provisions peaked at $228.6 million during Q2 2021, and registered a low of -$242.4 million during Q3 2025.
  • Over the past 5 years, Jazz Pharmaceuticals' median Tax Provisions value was -$17.6 million (recorded in 2021), while the average stood at -$23.0 million.
  • Its Tax Provisions has fluctuated over the past 5 years, first skyrocketed by 31719.16% in 2021, then crashed by 295895.52% in 2023.
  • Over the past 5 years, Jazz Pharmaceuticals' Tax Provisions (Quarter) stood at -$12.5 million in 2021, then plummeted by 701.36% to -$100.0 million in 2022, then soared by 66.92% to -$33.1 million in 2023, then plummeted by 75.02% to -$57.9 million in 2024, then tumbled by 318.61% to -$242.4 million in 2025.
  • Its Tax Provisions was -$242.4 million in Q3 2025, compared to -$17.2 million in Q2 2025 and -$57.9 million in Q4 2024.